Characterization of[35S]-ATPαS and [3H]-α,β-MeATP binding sites in rat brain cortical synaptosomes: Regulation of ligand binding by divalent cations

British Journal of Pharmacology

Volumn 121, Issue 5, 1997, Pages 913-922

  Schäfer, Rainer ^a   Reiser, Georg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Diadenosine polyphosphates; P(2X) purinoceptors; P(2Y) purinoceptors; Purinoceptors; Synaptosomes

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CALCIUM ION; CIBACRON BLUE F3GA; DEOXYADENOSINE TRIPHOSPHATE; DIADENOSINE PENTAPHOSPHATE; DIVALENT CATION; EVANS BLUE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; MAGNESIUM ION; NUCLEOTIDE; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; SURAMIN; URIDINE TRIPHOSPHATE; ADENOSINE 5' (1 THIO)TRIPHOSPHATE; ADENOSINE 5'-(1-THIO)TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; CALCIUM; DRUG DERIVATIVE; LIGAND; MAGNESIUM; PURINE P2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN CORTEX; CONTROLLED STUDY; LIGAND BINDING; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CATIONS, DIVALENT; CEREBRAL CORTEX; GUANOSINE TRIPHOSPHATE; LIGANDS; MAGNESIUM; RATS; RECEPTORS, PURINERGIC P2; SYNAPTOSOMES; THIONUCLEOTIDES;

EID: 0030610652     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701217     Document Type: Article

References (50)

1. 2XATP receptors in the rat brain. Br. J. Pharmacol., 115, 302-306.
2. BEAN, B.P. (1990). ATP-activated channels in rat and bullfrog sensory neurons: Concentration dependence and kinetics. J. Neurosci., 10, 1-10.
3. 3H]-α,β-methylene ATP binding sites in rat brain and spinal cord. Neuro Report, 5, 1601-1604.
4. BO, X., ZHANG, Y., NASSAR, M., BURNSTOCK, G. & SCHOEPFER, R. (1995). A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett., 375, 129-133.
5. 2Y purinergic receptor agonists and guanine nucleotides. J. Biol. Chem., 264, 884-890.
6. BRAKE, A.J., WAGENBACH, M.J. & JULIUS, D. (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature, 371, 519-523.
7. 2Y-purinergic receptor. J. Neurochem., 55, 1569-1575.
8. BURNSTOCK, G. (1990). Purinergic mechanisms. Ann. New York Acad. Sci., 603, 1-17.
9. 2X receptor expressed in epithelia and brain. EMBO J., 15, 55-62.
10. 2+ release in bovine adrenal chromaffin and endothelial cells. Pflügers Arch., 426, 524-533.
11. CHAREST, R., BLACKMORE, P.F. & EXTON, J.H. (1985). Characterization of responses of isolated rat hepatocytes to ATP and ADP. J. Biol. Chem., 260, 15789-15794.
12. 2+ ions. J. Neurophysiol., 73, 312-319.
13. 2Y purinergic receptor. J. Biol. Chem., 264, 6202-6206.
14. i oscillations which depend on cytosolic pH. Glia, 16, 108-116.
15. 2+ responses. Biochem. J., 320, 215-219.
16. EDWARDS, F.A., GIBB, A.J. & COLQUHOUN, D. (1992). ATP receptor-mediated synaptic currents in the central nervous system. Nature, 359, 144-147.
17. EVANS, R.J., DERKACH, V. & SURPRENANT, A. (1992). ATP mediates fast synaptic transmission in mammalian neurons. Nature, 357, 503-505.
18. 4-receptor. J. Pharmacol. Exp. Ther., 255, 46-51.
19. FILTZ, T.M., LI, Q., BOYER, J.L., NICHOLAS, R.A. & HARDEN, T.K. (1994). Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. Mol. Pharmacol., 46, 8-14.
20. 3 formation and fluctuating chloride current response induced by external ATP in Xenopus oocytes injected with embryonic guinea pig brain mRNA. FEBS Lett., 277, 205-208.
21. GORDON-WEEKS, P.R. (1987). Isolation of synaptosomes, growth cones and their subcellular components. In Neurochemistry: A practical Approach ed. Turner, A.J. & Bachelard, H.S., pp. 1-26, Washington, DC: IRL Press.
22. 2-purinergic receptors: Subtype-associated signaling responses and structure. Annu. Rev. Pharmacol. Toxicol., 35, 541-579.
23. HOURANI, S.M.O. & HALL, D.A. (1994). Receptors for ADP on human blood platelets. Trends Pharmacol. Sci., 15, 103-108.
24. ILLES, P. & NÖRENBERG, W. (1993). Neuronal ATP receptors and their mechanism of action. Trends. Pharmacol. Sci., 14, 50-54.
25. KEPPENS, V., VANDEKERCKHOVE, A. & DE WULF, H. (1989). Characterization of purinoceptors present on human liver plasma membranes. FEBS Lett., 248, 137-140.
26. KRISHTAL, O.A., MARCHENKO, S.M., OBUKHOV, A.G. & VOLKOVA, T.M. (1988). Receptors for ATP in rat sensory neurones: the structure-function relationship for ligands. Br. J. Pharmacol., 95, 1057-1062.
27. 3H]α,β-methylene ATP binding sites in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 608-617.
28. 3H]α,β-methylene ATP binding in rat vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 113-122.
29. 35S]-adenosine 5′-O-[3-thiotriphosphate] in rat vas deferens membranes. Br. J. Pharmacol., 117, 63-70.
30. 33P]-ATP. Br. J. Pharmacol., 117, 1254-1260.
31. 2 purinoceptors in the guinea-pig cochlea. Hear. Res., 84, 177-193.
32. ONRUST, R., HERZMARK, P., CHI, P., GARCIA, P.D., LICHTARGE, O., KINGSLEY, C. & BOURNE, H.R. (1997). Receptor and βγ binding sites in the a subunit of the retinal G protein transduction. Science, 275, 381-384.
33. 2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. U.S.A., 91, 3275-3279.
34. 2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase. Biochem. Pharmacol., 51, 1453-1460.
35. 2 purinoceptors present on rat brain synaptic terminals. Br. J. Pharmacol., 108, 1094-1099.
36. PINTOR, J. & MIRAS-PORTUGAL, M.T. (1995). A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes. Br. J. Pharmacol., 115, 895-902.
37. RALEVIC, V., HOYLE, C.H.V. & BURNSTOCK, G. (1995). Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator action of adenine dinucleotides in rat mesenteric arteries. J. Physiol., 483, 703-713.
38. 2-purinergic/pyrimidinergic receptor. J. Neurochem., 64, 61-68.
39. SCHLÜTER, H., OFFERS, E., BRÜGGEMANN, G., VAN DER GIET, M., TEPEL, M., NORDHOFF, E., KARAS, M., SPIEKER, C., WITZEL, H. & ZIDEK, W. (1994). Diadenosine phosphates and the physiological control of blood pressure. Nature, 367, 186-188.
40. 2Y purinoceptor in the brain. Pharmacol. Toxicol., 76, 302-307.
41. 4: an ATP-activated inotropic receptor cloned from rat brain. Proc. Natl. Acad. Sci. U.S.A., 93, 3684-3688.
42. STONE, T.W. & PERKINS, M.N. (1981). Adenine dinucleotide effect on rat cortical neurones. Brain Res., 229, 241-245.
43. SUN, X.P. & STANLEY, E.F. (1996). An ATP-activated, ligand-gated ion channel on a cholinergic presynaptic nerve terminal. Proc. Natl. Acad. Sci. U.S.A., 93, 1859-1863.
44. 2x receptor for extracellular ATP. Nature, 371, 516-519.
45. 2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. Br. J. Pharmacol., 113, 815-822.
46. WEBB, T.E., SIMON, J., KRISHEK, B.J., BATESON, A.N., SMART, T.G., KING, B.F., BURNSTOCK, G. & BARNARD, E.A. (1993). Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett., 324, 219-225.
47. 35S]adenosine 5′-O-(2-thiodiphosphate) to endothelial cells in culture. Biochem. Pharmacol., 49, 1411-1418.
48. 2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 491-497.
49. ZIGANSHIN, A.U., ZIGANSHINA, L.E., KING, B.F., PINTOR, J. & BURNSTOCK, G. (1996). Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus laevis. Biochem. Pharmacol., 51, 897-901.
50. ZIMMERMANN, H. (1994). Signalling via ATP in the nervous system. Trends Neurosci., 17, 420-426.